Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as doxorubicin and gemcitabine, use different
ways to stop tumor cells from dividing so they stop growing or die. Combining more than one
drug may kill more tumor cells.
PURPOSE: This phase II trial is studying how well giving doxorubicin together with
gemcitabine works in treating patients with locally recurrent or metastatic unresectable
renal cell carcinoma (kidney cancer).